Gujarat FDCA-ONDCP discuss illegal production and export of narcotic & habit-forming drugs: Shardul Nautiyal, Mumbai Saturday ...

Chennai to host IDMA's NEC and TN chapter's AGM at Fortune Beach Resort on Aug 16: Peethaambaran Kunnathoor, Chennai Saturday, August 16, 2025, 08:00 Hrs [IST] The National Execut ...

Ayush ministry reports fund utilisation above 95% by research councils during the last five years: Gireesh Babu, New Delhi Saturday, August 16, 2025, 08:00 Hrs [IST] The three aut ...

Indian healthcare eyes Large Language Models to tackle fragmented data & ease clinical burden: Nandita Vijayasimha, Bengaluru Saturday, August 16, 2025, 08:00 Hrs [IST] Indian hea ...

Women entrepreneurs open almost 59% of total JAKs set up in last three years: Gireesh Babu, New Delhi Saturday, August 16, 2025, 08:00 Hrs [IST] The Jan Aushadhi Kendra (JAK) phar ...

Pilatus Biosciences inks clinical trial collaboration with Roche to evaluate PLT012 in first-in-human study in hepatocellular carcinoma: Epalinges, Switzerland Saturday, August 16 ...

Leads Biolabs completes patient enrollment in pivotal trial of Opamtistomig monotherapy for extrapulmonary neuroendocrine carcinoma: Nanjing, China Saturday, August 16, 2025, 14:0 ...

AleraCare, PURE Healthcare enter into merger agreement to enhance availability of infusion services: Phoenix Saturday, August 16, 2025, 15:00 Hrs [IST] AleraCare, a leading provid ...

Vyome Therapeutics receives Nasdaq Stock Market approval to merge with ReShape Lifesciences: Cambridge, Massachusetts Saturday, August 16, 2025, 17:00 Hrs [IST] Vyome Therapeutics ...

Study reveals how small changes in walking technique may help treat knee osteoarthritis: New York Saturday, August 16, 2025, 16:00 Hrs [IST] Gait analysis and pain measures show t ...

Basilea Pharma enters licensing pact with Venatorx Pharma to acquire rights to ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral BL/BLI combo to treat cUTI Allschwil, Switzerland ...

EMA grants orphan designation to Sanofi’s rilzabrutinib, a reversible covalent BTK inhibitor, for IgG4-related disease: Paris Saturday, August 16, 2025, 09:00 Hrs [IST] Sanofi a ...